Post-approval studies (Phase 4)Looking for participantsNCT07323524What this trial is testingDapagliflozin in Active Lupus NephritisWho this might be right forLupus Nephritis (LN) Brigham and Women's Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06419205What this trial is testingEvaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWho this might be right forIgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy Akebia Therapeutics 30
Not applicableStudy completedNCT00000895What this trial is testingLearn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionWho this might be right forMycobacterium Avium-intracellulare InfectionHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Study completedNCT02472795What this trial is testingClinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Viatris Innovation GmbH 105
Not applicableStudy completedNCT03750929What this trial is testingAerobic Capacity and Strength Exercise in Takayasu's ArteritisWho this might be right forPhysical ActivityTakayasu Arteritis University of Sao Paulo 12
Large-scale testing (Phase 3)Study completedNCT05326841What this trial is testingEffect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .Who this might be right forLupus Erythematosus, SystemicCholecalciferol SupplementationDisease Activity+1 more Dr Cipto Mangunkusumo General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03453619What this trial is testingPhase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesWho this might be right forIgA NephropathyLupus NephritisMembranous Nephropathy+2 more Apellis Pharmaceuticals, Inc. 21
Very early researchNot Yet RecruitingNCT06982534What this trial is testingClinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.Who this might be right forSystemic Sclerosis (SSc) PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Large-scale testing (Phase 3)UnknownNCT04275193What this trial is testingThe Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Shanghai University of Traditional Chinese Medicine 118
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419What this trial is testingRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesWho this might be right forRheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more University of Sao Paulo General Hospital 2,005
Not applicableUnknownNCT05253638What this trial is testingEvaluation Of Serum MIF Level in SLE PatientsWho this might be right forSystemic Lupus Erythematosus Assiut University 60
Very early researchLooking for participantsNCT07000682What this trial is testingThe Clinical Study on the Treatment of SSc With UTAA91 Injection.Who this might be right forSystemic Sclerosis (SSc) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT00997100What this trial is testingExploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Active Biotech AB 13
Testing effectiveness (Phase 2)Study completedNCT00426764What this trial is testingA Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Celgene 131
Not applicableNot Yet RecruitingNCT06610409What this trial is testingAssessment of CXCL5 Level in SLE Patients and Its Correlation with Disease ActivityWho this might be right forSLE (Systemic Lupus) Assiut University 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06109272What this trial is testingAssess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma AbbVie 89
Testing effectiveness (Phase 2)Ended earlyNCT03407482What this trial is testingAn Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic Genentech, Inc. 160
Testing effectiveness (Phase 2)UnknownNCT00128583What this trial is testingVaccine Therapy in Treating Patients With Malignant MelanomaWho this might be right forMelanoma (Skin) CancerVax Corporation
Testing effectiveness (Phase 2)Study completedNCT02962960What this trial is testingCharacterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin ManifestationsWho this might be right forSystemic Lupus Erythematosus AstraZeneca 36
Large-scale testing (Phase 3)Study completedNCT01551069What this trial is testingMulticenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionWho this might be right forCutaneous Lupus Erythematosus-Systemic Lupus Erythematosus Sanofi 103